Switch theme
Sign up to access all valuation multiples
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
1992
748
LTM Revenue $285M
LTM EBITDA $6.3M
$358M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
AngioDynamics has a last 12-month revenue of $285M and a last 12-month EBITDA of $6.3M.
In the most recent fiscal year, AngioDynamics achieved revenue of $304M and an EBITDA of -$6.1M.
AngioDynamics expects next 12-month revenue of XXX and NTM EBITDA of XXX
See AngioDynamics valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $339M | $304M | XXX | XXX | XXX |
| Gross Profit | $166M | $174M | XXX | XXX | XXX |
| Gross Margin | 49% | 57% | XXX | XXX | XXX |
| EBITDA | -$20.9M | -$6.1M | XXX | XXX | XXX |
| EBITDA Margin | -6% | -2% | XXX | XXX | XXX |
| Net Profit | -$26.5M | -$52.4M | XXX | XXX | XXX |
| Net Margin | -8% | -17% | XXX | XXX | XXX |
| Net Debt | $5.0M | $20.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, AngioDynamics's stock price is $10.
AngioDynamics has current market cap of $398M, and EV of $358M.
See AngioDynamics trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $358M | $398M | XXX | XXX | XXX | XXX | $-0.27 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, AngioDynamics has market cap of $398M and EV of $358M.
AngioDynamics's trades at 1.3x LTM EV/Revenue multiple, and 56.6x LTM EBITDA.
Analysts estimate AngioDynamics's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for AngioDynamics and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $358M | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | XXX | XXX |
| EV/EBITDA | 184.7x | XXX | XXX | XXX |
| P/E | -4.7x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAngioDynamics's NTM/LTM revenue growth is 6%
AngioDynamics's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, AngioDynamics's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate AngioDynamics's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for AngioDynamics and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -10% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 1% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -71% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 7% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.4M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 34% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 14% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 10% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 62% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AngioDynamics acquired XXX companies to date.
Last acquisition by AngioDynamics was XXXXXXXX, XXXXX XXXXX XXXXXX . AngioDynamics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was AngioDynamics founded? | AngioDynamics was founded in 1992. |
| Where is AngioDynamics headquartered? | AngioDynamics is headquartered in United States of America. |
| How many employees does AngioDynamics have? | As of today, AngioDynamics has 748 employees. |
| Who is the CEO of AngioDynamics? | AngioDynamics's CEO is Mr. James C. Clemmer. |
| Is AngioDynamics publicy listed? | Yes, AngioDynamics is a public company listed on NAS. |
| What is the stock symbol of AngioDynamics? | AngioDynamics trades under ANGO ticker. |
| When did AngioDynamics go public? | AngioDynamics went public in 2004. |
| Who are competitors of AngioDynamics? | Similar companies to AngioDynamics include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of AngioDynamics? | AngioDynamics's current market cap is $398M |
| What is the current revenue of AngioDynamics? | AngioDynamics's last 12-month revenue is $285M. |
| What is the current EBITDA of AngioDynamics? | AngioDynamics's last 12-month EBITDA is $6.3M. |
| What is the current EV/Revenue multiple of AngioDynamics? | Current revenue multiple of AngioDynamics is 1.3x. |
| What is the current EV/EBITDA multiple of AngioDynamics? | Current EBITDA multiple of AngioDynamics is 56.6x. |
| What is the current revenue growth of AngioDynamics? | AngioDynamics revenue growth between 2023 and 2024 was -10%. |
| Is AngioDynamics profitable? | Yes, AngioDynamics is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
